Measures to Reduce Mother-to-Child Transmission of Hepatitis B Virus in China: A Meta-Analysis

[21] Bai GQ(2009)A study on the treatment of chronic hepatitis B with YMDD mutation Chin J Hepatol 17 171-1503

[22] Shi L(2011)Lamivudine plus adefovir combination therapy versus entecavir monotherapy for lamivudine-resistant chronic hepatitis B: a systematic review and meta-analysis Virol J 8 393-3437

[23] Jiang H(2006)Antepartum immunoprophylaxis of three doses of hepatitis B immunoglobulin is not effective: a single-centre randomized study J Viral Hepat 13 597-39

[24] Bai H(2003)Interruption of HBV intrauterine transmission: a clinical study World J Gastroenterol 9 1501-147

[25] Zhang L(2006)A randomized controlled clinical trial: interruption of intrauterine transmission of hepatitis B virus infection with HBIG World J Gastroenterol 12 3434-63

[26] Ma L(1999)Prevention of intrauterine infection by hepatitis B virus with hepatitis B immune globulin: efficacy and mechanism Chin Med J 112 37-103

[27] Dou XG(1997)A preliminary study on interruption of HBV transmission in uterus Chin Med J 110 145-1221

[28] Feng GH(2008)A randomized controlled trial on effect of hepatitis B immune globulin in preventing hepatitis B virus transmission from mothers to infants Chin J Pediatr 46 61-912

[29] Zhao GZ(2009)Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study J Viral Hepat 16 94-526

[30] Xu DZ(2011)A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection J Hepatol 55 1215-2218

[21] Bai GQ(2009)A study on the treatment of chronic hepatitis B with YMDD mutation Chin J Hepatol 17 171-1503

[22] Shi L(2011)Lamivudine plus adefovir combination therapy versus entecavir monotherapy for lamivudine-resistant chronic hepatitis B: a systematic review and meta-analysis Virol J 8 393-3437

[23] Jiang H(2006)Antepartum immunoprophylaxis of three doses of hepatitis B immunoglobulin is not effective: a single-centre randomized study J Viral Hepat 13 597-39

[24] Bai H(2003)Interruption of HBV intrauterine transmission: a clinical study World J Gastroenterol 9 1501-147

[25] Zhang L(2006)A randomized controlled clinical trial: interruption of intrauterine transmission of hepatitis B virus infection with HBIG World J Gastroenterol 12 3434-63

[26] Ma L(1999)Prevention of intrauterine infection by hepatitis B virus with hepatitis B immune globulin: efficacy and mechanism Chin Med J 112 37-103

[27] Dou XG(1997)A preliminary study on interruption of HBV transmission in uterus Chin Med J 110 145-1221

[28] Feng GH(2008)A randomized controlled trial on effect of hepatitis B immune globulin in preventing hepatitis B virus transmission from mothers to infants Chin J Pediatr 46 61-912

[29] Zhao GZ(2009)Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study J Viral Hepat 16 94-526

[30] Xu DZ(2011)A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection J Hepatol 55 1215-2218